Hänggi W, Katz M, Fravi R, König C, Dreher E
Universitäts-Frauenklinik Bern.
Schweiz Rundsch Med Prax. 1990 Nov 6;79(45):1387-9.
The clinical staging of the malignoma of the uterine corpus according to the FIGO classification corresponds in only 85.7% in stage I and 35.7% in stage II to the histopathologic staging after operation. Tumor grading and histology from D and C differ in 31.8% and 9.4% respectively from the hysterectomy specimen. We propose therefore to prefer surgical and histopathological staging to the pure clinical FIGO-staging in order to plan adjuvant therapy and for comparing therapeutic results of different patient groups as well.
根据国际妇产科联盟（FIGO）分类的子宫体恶性肿瘤临床分期，I期仅85.7%、II期仅35.7%与术后组织病理学分期相符。D组和C组的肿瘤分级及组织学与子宫切除标本相比，分别有31.8%和9.4%存在差异。因此，我们建议，为了规划辅助治疗以及比较不同患者组的治疗效果，相较于单纯的FIGO临床分期，更应优先采用手术和组织病理学分期。
